Charles Schwab
BHVN icon

Charles Schwab’s Biohaven BHVN Stock Holding History

Charles Schwab’s Portfolio BHVN Stock Details BHVN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$16.5M Buy
1,109,283
+168,206
+18% +$1.81M ﹤0.01% 1917
2026
Q1 		$7.96M Buy
941,077
+93,665
+11% +$1.02M ﹤0.01% 2207
2025
Q4 		$9.57M Buy
847,412
+97,691
+13% +$1.21M ﹤0.01% 2164
2025
Q3 		$11.3M Buy
749,721
+37,666
+5% +$548K ﹤0.01% 2058
2025
Q2 		$10M Buy
712,055
+24,554
+4% +$438K ﹤0.01% 2012
2025
Q1 		$16.5M Sell
687,501
-13,813
-2% -$487K ﹤0.01% 1722
2024
Q4 		$26.2M Buy
701,314
+68,624
+11% +$3.2M ﹤0.01% 1551
2024
Q3 		$31.6M Buy
632,690
+32,769
+5% +$1.27M 0.01% 1430
2024
Q2 		$20.8M Buy
599,921
+64,741
+12% +$2.56M ﹤0.01% 1661
2024
Q1 		$29.3M Buy
535,180
+16,276
+3% +$806K 0.01% 1388
2023
Q4 		$22.2M Buy
518,904
+86,890
+20% +$2.7M 0.01% 1538
2023
Q3 		$11.2M Sell
432,014
-70,280
-14% -$1.46M ﹤0.01% 1855
2023
Q2 		$12M Sell
502,294
-10,056
-2% -$173K ﹤0.01% 1826
2023
Q1 		$7M Buy
512,350
+1,430
+0.3% +$22.8K ﹤0.01% 2049
2022
Q4 		$7.09M Buy
+510,920
New +$7.21M ﹤0.01% 2031

Other funds holding BHVN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
IAM
Infinitum Asset Management Fort Lauderdale, Florida $983M AUM 26.53% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab's BHVN Position: Q2 2026 in Review

Charles Schwab increased its Biohaven (BHVN) stake by 18% in Q2 2026, buying an estimated $1.81M and bringing the position to 1,109,283 shares worth $16.5M. The position accounts for ﹤0.01% of the portfolio, ranked #1917.

Charles Schwab first reported a position in BHVN in Q4 2022 and has held it in 15 quarters since. The position peaked at $31.6M in Q3 2024. 293 funds tracked by Wall St. Rank hold BHVN as of Q2 2026.

  • Charles Schwab held 1,109,283 shares of Biohaven worth $16.5M as of Q2 2026.
  • Charles Schwab bought 168,206 Biohaven shares in Q2 2026, an estimated $1.81M.
  • Biohaven made up ﹤0.01% of Charles Schwab's portfolio in Q2 2026, its #1917 holding.
  • Charles Schwab first reported a position in Biohaven in Q4 2022 and has held it in 15 quarters since.
  • Charles Schwab's Biohaven position peaked at $31.6M in Q3 2024.
  • 293 funds tracked by Wall St. Rank held Biohaven as of Q2 2026.

Based on Charles Schwab's 13F filing for Q2 2026, filed 14 Aug 2026.